Epilysin (MMP-28) - Structure, expression and potential functions

Experimental Dermatology

Volumn 17, Issue 11, 2008, Pages 897-907

  Illman, Sara A ^a   Lohi, Jouko ^a   Keski Oja, Jorma ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; EPILYSIN; GROWTH FACTOR; HISTONE DEACETYLASE INHIBITOR; MATRIX METALLOPROTEINASE; NERVE CELL ADHESION MOLECULE; PEPTIDE; PROTEINASE INHIBITOR; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN;

CANCER CELL; CANCER STAGING; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELLULAR DISTRIBUTION; DOWN REGULATION; DRUG BINDING SITE; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIUM CELL; GENE CONTROL; HOMEOSTASIS; HUMAN; KERATINOCYTE; LUNG ADENOCARCINOMA; MALIGNANT NEOPLASTIC DISEASE; MESENCHYME CELL; NONHUMAN; PHASE TRANSITION; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; WOUND HEALING; XENOPUS LAEVIS;

AMINO ACID SEQUENCE; ANIMALS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MATRIX METALLOPROTEINASES, SECRETED; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 54049130859     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2008.00782.x     Document Type: Review

References (106)

1. Gross J, Lapiere C M. Collagenolytic activity in amphibian tissues: A tissue culture assay. Proc Natl Acad Sci U S A 1962: 48: 1014-1022.
2. Sternlicht M D, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001: 17: 463-516.
3. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002: 2: 161-174.
4. Page-McCaw A, Ewald A J, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007: 8: 221-233.
5. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006: 69: 562-573.
6. Van Wart H E, Birkedal-Hansen H. The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci U S A 1990: 87: 5578-5582.
7. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res 2003: 92: 827-839.
8. Muller D, Quantin B, Gesnel M C, Millon-Collard R, Abecassis J, Breathnach R. The collagenase gene family in humans consists of at least four members. Biochem J 1998: 253: 187-192.
9. Park H I, Ni J, Gerkema F E, Liu D, Belozerov V E, Sang Q X. Identification and characterization of human endometase (matrix metalloproteinase-26) from endometrial tumor. J Biol Chem 2000: 275: 20540-20544.
10. Pei D. CA-MMP: A matrix metalloproteinase with a novel cysteine array, but without the classic cysteine switch. FEBS Lett 1999: 457: 262-270.
11. Velasco G, Pendas A M, Fueyo A, Knauper V, Murphy G, Lopez-Otin C. Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members. J Biol Chem 1999: 274: 4570-4576.
12. Lambert E, Dasse E, Haye B, Petitfrere E. TIMPs as multifacial proteins. Crit Rev Oncol Hematol 2004: 49: 187-198.
13. Fujimoto N, Terlizzi J, Aho S et al. Extracellular matrix protein 1 inhibits the activity of matrix metalloproteinase 9 through high-affinity protein/protein interactions. Exp Dermatol 2006: 4: 300-307.
14. Chan I, Liu L, Hamada T, Sethuraman G, McGarth J A. The molecular basis of lipoid proteinosis: Mutations in extracellular matrix protein 1. Exp Dermatol 2007: 16: 881-890.
15. Oh J, Takahashi R, Kondo S et al. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 2001: 107: 789-800.
16. Lohi J, Wilson C L, Roby J D, Parks W C. Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury. J Biol Chem 2001: 276: 10134-10144.
17. Marchenko G N, Strongin A Y. MMP-28, a new human matrix metalloproteinase with an unusual cysteine-switch sequence is widely expressed in tumors. Gene 2001: 265: 87-93.
18. Illman S A, Keski-Oja J, Parks W C, Lohi J. The mouse matrix metalloproteinase, epilysin (MMP-28), is alternatively spliced and processed by a furin-like proprotein convertase. Biochem J 2003: 375: 191-197.
19. Bassi D E, Fu J, Lopez de Cicco R, Klein-Szanto A J. Proprotein convertases: "master switches" in the regulation of tumor growth and progression. Mol Carcinog 2005: 44: 151-161.
20. Werner S R, Mescher A L, Neff A W et al. Neural MMP-28 expression precedes myelination during development and peripheral nerve repair. Dev Dyn 2007: 236: 2852-2864.
21. Pei D, Weiss S J. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 1995: 375: 244-247.
22. Cao J, Hymowitz M, Conner C, Bahou W F, Zucker S. The propeptide domain of membrane type 1-matrix metalloproteinase acts as an intramolecular chaperone when expressed in trans with the mature sequence in COS-1 cells. J Biol Chem 2000: 275: 29648-29653.
23. Pavlaki M, Cao J, Hymowitz M, Chen W T, Bahou W, Zucker S. A conserved sequence within the propeptide domain of membrane type 1 matrix metalloproteinase is critical for function as an intramolecular chaperone. J Biol Chem 2002: 277: 2740-2749.
24. Cossins J, Dudgeon T J, Catlin G, Gearing A J, Clements J M. Identification of MMP-18, a putative novel human matrix metalloproteinase. Biochem Biophys Res Commun 1996: 228: 494-498.
25. Pendas A M, Knauper V, Puente X S et al. Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution. J Biol Chem 1997: 272: 4281-4286.
26. Anglard P, Melot T, Guerin E, Thomas G, Basset P. Structure and promoter characterization of the human stromelysin-3 gene. J Biol Chem 1995: 270: 20337-20344.
27. Mueller M S, Mauch S, Sedlacek R. Structure of the human MMP-19 gene. Gene 2000: 252: 27-37.
28. Li Q L, Illman S A, Wang H M, Liu D L, Lohi J, Zhu C. Matrix metalloproteinase-28 transcript and protein are expressed in rhesus monkey placenta during early pregnancy. Mol Hum Reprod 2003: 9: 205-211.
29. Bernal F, Hartung H P, Kieseier B C. Tissue mRNA expression in rat of newly described matrix metalloproteinases. Biol Res 2005: 38: 267-271.
30. Ra H J, Parks W C. Control of matrix metalloproteinase catalytic activity. Matrix Biol 2007: 26: 587-596.
31. RenòF, Traina V, Gatti S, Battistella E, Cannas M. Functionalization of a Poly (d, l) lactic acid surface with galactose to improve human keratinocyte behaviour for artificial epidermis. Biotechnol Bioeng 2008: 100: 195-202.
32. Kevorkian L, Young D A, Darrah C et al. Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum 2004: 50: 131-141.
33. Davidson R K, Waters J G, Kevorkian L et al. Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage. Arthritis Res Ther 2006: 8: R124.
34. Momohara S, Okamoto H, Komiya K et al. Matrix metalloproteinase 28/ MMP-28 expression in cartilage from patients with rheumatoid arthritis and osteoarthritis: Comment on the article by Kevorkian et al. Arthritis Rheum 2004: 50: 4074-4075.
35. Djouad F, Delorme B, Maurice M et al. Microenvironmental changes during differentiation of mesenchymal stem cells towards chondrocytes. Arthritis Res Ther 2007: 9: R33.
36. Urso M L, Scrimgeour A G, Chen Y W, Thompson P D, Clarkson P M. Analysis of human skeletal muscle after 48h immobilization reveals alterations in mRNA and protein for extracellular matrix components. J Appl Physiol 2006: 101: 1136-1148.
37. RenòF, Sabbatini M, Stella M, Magliacani G, Cannas M. Effect of in vitro mechanical compression on MMP-28 (matrix metalloproteinase-28) expression in hypertrophic scars. Wound Repair Regen 2005: 13: 255-261.
38. Bister V O, Salmela M T, Karjalainen-Lindsberg M L et al. Differential expression of three matrix metalloproteinases, MMP-19, MMP-26, and MMP-28, in normal and inflamed intestine and colon cancer. Dig Dis Sci 2004: 49: 653-661.
39. Bar-Or A, Nuttall R K, Duddy M et al. Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. Brain 2003: 126: 2738-2749.
40. Saarialho-Kere U, KerkeläE, Jahkola T, Suomela S, Keski-Oja J, Lohi J. Epilysin (MMP-28) expression is associated with cell proliferation during epithelial repair. J Invest Dermatol 2002: 119: 14-21.
41. King M W, Nguyen T, Calley J et al. Identification of genes expressed during Xenopus laevis limb regeneration by using subtractive hybridization. Dev Dyn 2003: 226: 398-409.
42. Gill S E, Parks W C. Metalloproteinases and their inhibitors: Regulators of wound healing. Int J Biochem Cell Biol 2008: 40: 1334-1347.
43. Impola U, Toriseva M, Suomela S et al. Matrix metalloproteinase-19 is expressed by proliferating epithelium but disappears with neoplastic dedifferentiation. Int J Cancer 2003: 103: 709-716.
44. Folgueras A R, Pendas A M, Sanchez L M, Lopez-Otin C. Matrix metalloproteinases in cancer: From new functions to improved inhibition strategies. Int J Dev Biol 2004: 48: 411-424.
45. Hegedüs L, Cho H, Xie X, Eliceiri G L. Additional MDA-MB-231 breast cancer cell matrix metalloproteinases promote invasiveness. J Cell Physiol 2008: 216: 480-485.
46. Overall C M, Tam E M, Kappelhoff R et al. Protease degradomics: Mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors. Biol Chem 2004: 385: 493-504.
47. Wallard M J, Pennington C J, Veerakumarasivam A et al. Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma. Br J Cancer 2006: 94: 569-577.
48. Kasper G, Reule M, Tschirschmann M et al. Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: Involvement of the IGF-1 signalling pathway. BMC Cancer 2007: 17: 7-12.
49. Kuivanen T, Ahokas K, Virolainen S et al. MMP-21 is upregulated at early stages of melanoma progression but disappears with more aggressive phenotype. Virchows Arch 2005: 447: 954-960.
50. Lin M H, Liu S Y, Su H J, Liu Y C. Functional role of matrix metalloproteinase-28 in the oral squamous cell carcinoma. Oral Oncol 2006: 42: 907-913.
51. Thiery J P. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002: 2: 442-454.
52. Huber M A, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005: 17: 548-558.
53. Kalluri R, Neilson E G. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003: 112: 1776-1784.
54. Bissell M J, Radisky D. Putting tumours in context. Nat Rev Cancer 2001: 1: 46-54.
55. Tse J C, Kalluri R. Mechanisms of metastasis: Epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem 2007: 101: 816-829.
56. Mani S A, Guo W, Liao M J et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008: 133: 704-715.
57. Illman S A, Lehti K, Keski-Oja J, Lohi J. Epilysin (MMP-28) induces TGF-β mediated epithelial to mesenchymal transition in lung carcinoma cells. J Cell Sci 2006: 119: 3856-3865.
58. Zavadil J, Böttinger E P. TGF-β and epithelial-to-mesenchymal transitions. Oncogene 2005: 24: 5764-5774.
59. Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev 2000: 14: 163-176.
60. D'Angelo M, Sarment D P, Billings P C, Pacifici M. Activation of transforming growth factor β in chondrocytes undergoing endochondral ossification. J Bone Miner Res 2001: 16: 2339-2347.
61. Karsdal M A, Larsen L, Engsig M T et al. Matrix metalloproteinase-dependent activation of latent transforming growth factor-β controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J Biol Chem 2002: 277: 44061-44067.
62. 8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1. J Cell Biol 2002: 157: 493-507.
63. Ge G, Greenspan D S. BMP1 controls TGFβ1 activation via cleavage of latent TGFβ-binding protein. J Cell Biol 2006: 175: 111-120.
64. Lochter A, Galosy S, Muschler J, Freedman N, Werb Z, Bissell M J. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol 1997: 139: 1861-1872.
65. Radisky D C, Levy D D, Littlepage L E et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005: 436: 123-127.
66. NoëV, Fingleton B, Jacobs K et al. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 2001: 114: 111-118.
67. McGuire J K, Li Q, Parks W C. Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. Am J Pathol 2003: 162: 1831-1843.
68. Covington M D, Burghardt R C, Parrish A R. Ischemia-induced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14). Am J Physiol Renal Physiol 2006: 290: 43-51.
69. Symowicz J, Adley B P, Gleason K J et al. Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells. Cancer Res 2007: 67: 2030-2039.
70. Cao J, Chiarelli C, Richman O, Zarrabi K, Kozarekar P, Zucker S. Membrane type 1-matrix metalloproteinase (MT1-MMP) induces epithelial-to-mesenchymal transition (EMT) in prostate cancer. J Biol Chem 2008: 283: 6232-6240.
71. Hotary K, Allen E, Punturieri A, Yana I, Weiss S J. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol 2000: 149: 1309-1323.
72. Sabeh F, Ota I, Holmbeck K et al. Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J Cell Biol 2004: 167: 769-781.
73. Hotary K, Li X Y, Allen E, Stevens S L, Weiss S J. A cancer cell metalloprotease triad regulates the basement membrane transmigration program. Genes Dev 2006: 20: 2673-2686.
74. Leivonen S K, Ala-Aho R, Koli K, Grenman R, Peltonen J, Kähäri V M. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells. Oncogene 2006: 25: 2588-2600.
75. Orlichenko L S, Radisky D C. Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development. Clin Exp Metastasis 2008 (in press).
76. Kähäri V M, Saarialho-Kere U. Matrix metalloproteinases in skin. Exp Dermatol 1997: 5: 199-213.
77. Yan C, Boyd D D. Regulation of matrix metalloproteinase gene expression. J Cell Physiol 2007: 211: 19-26.
78. Lohi J, Lehti K, Valtanen H, Parks W C, Keski-Oja J. Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene. Gene 2000: 242: 75-86.
79. Clark I M, Swingler T E, Young D A. Acetylation in the regulation of metalloproteinase and tissue inhibitor of metalloproteinases gene expression. Front Biosci 2007: 12: 528-535.
80. Illman S A, Keski-Oja J, Lohi J. Promoter characterization of the human and mouse epilysin (MMP-28) genes. Gene 2001: 275: 185-194.
81. Li L, He S, Sun J M, Davie J R. Gene regulation by Sp1 and Sp3. Biochem Cell Biol 2004: 82: 460-471.
82. Suske G. The Sp-family of transcription factors. Gene 1999: 238: 291-300.
83. Apt D, Watts R M, Suske G, Bernard H U. High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter. Virology 1996: 224: 281-291.
84. Liu Y N, Lee W W, Wang C Y, Chao T H, Chen Y, Chen J H. Regulatory mechanisms controlling human E-cadherin gene expression. Oncogene 2005: 24: 8277-8290.
85. Young D A, Lakey R L, Pennington C J et.al. Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption. Arthritis Res Ther 2005: 7: R503-R512.
86. Brooks P C, Strömblad S, Sander L C et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αv β3. Cell 1996: 85: 683-693.
87. Yu Q, Stamenkovic I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 1999: 13: 35-48.
88. 1 integrin upon release from keratinocytes migrating on type I collagen. J Biol Chem 2001: 276: 29368-29374.
89. 2 integrin I domain/procollagenase-1 (matrix metalloproteinase-1) interaction. J Biol Chem 2001: 276: 29375-29381.
90. Yu W H, Woessner J F Jr. Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J Biol Chem 2000: 275: 4183-4191.
91. Yu W H, Woessner J F Jr, McNeish J D, Stamenkovic I. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev 2002: 16: 307-323.
92. Yamamoto K, Higashi S, Kioi M, Tsunezumi J, Honke K, Miyazaki K. Binding of active matrilysin to cell surface cholesterol sulfate is essential for its membrane-associated proteolytic action and induction of homotypic cell adhesion. J Biol Chem 2006: 14: 9170-9180.
93. Shiomi T, Inoki I, Kataoka F et al. Pericellular activation of proMMP-7 (promatrilysin-1) through interaction with CD151. Lab Invest 2005: 12: 1489-1506.
94. Illman S A. Molecular biology and functions of epilysin (MMP-28). Helsinki University Biomedical Dissertations 2007: 98. Available at http://oa.doria.fi/bitstream/handle/10024/29176/molecula.pdf?sequence=1.
95. Parks W C, Wilson C L, Lopez-Boado Y S. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004: 4: 617-629.
96. Martin M D, Matrisian L M. The other side of MMPs: Protective roles in tumor progression. Cancer Metastasis Rev 2007: 26: 717-724.
97. Vu T H, Werb Z. Matrix metalloproteinases: Effectors of development and normal physiology. Genes Dev 2000: 14: 2123-2133.
98. English W R, Velasco G, Stracke J O, Knäuper V, Murphy G. Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP-25). FEBS Lett 2001: 491: 137-142.
99. Ala-aho R, Kähäri V M. Collagenases in cancer. Biochimie 2005: 87: 273-286.
100. Gao G, Plaas A, Thompson V P, Jin S, Zou F, Sandy J D. ADAMTS4 (Aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1. J Biol Chem 2004: 279: 10042-10051.
101. Krampert M, Bloch W, Sasaki T et al. Activities of the matrix metalloproteinase stromelysin-2 (MMP-10) in matrix degradation and keratinocyte organization in wounded skin. Mol Biol Cell 2004: 15: 5242-5254.
102. Wielockx B, Libert C, Wilson C. Matrilysin (matrix metalloproteinase-7): a new promising drug target in cancer and inflammation? Cytokine Growth Factor Rev 2004: 15: 111-115.
103. Agrawal S, Anderson P, Durbeej M et al. Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J Exp Med 2006: 203: 1007-1019.
104. Egawa N, Koshikawa N, Tomari T, Nabeshima K, Isobe T, Seiki M. Membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14) cleaves and releases a 22-kDa extracellular matrix metalloproteinase inducer (EMMPRIN) fragment from tumor cells. J Biol Chem 2006: 281: 37576-37585.
105. Itoh Y, Seiki M. MT1-MMP: A potent modifier of pericellular microenvironment. J Cell Physiol 2006: 206: 1-8.
106. Sithu S D, English W R, Olson P et al. Membrane-type 1-matrix metalloproteinase regulates intracellular adhesion molecule-1 (ICAM-1)-mediated monocyte transmigration. J Biol Chem 2007: 282: 25010-25019.